{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:07:43Z","timestamp":1788473263927,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,24]],"date-time":"2015-05-24T00:00:00Z","timestamp":1432425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11011-015-9686-9","type":"journal-article","created":{"date-parts":[[2015,5,23]],"date-time":"2015-05-23T02:33:50Z","timestamp":1432348430000},"page":"1167-1174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation"],"prefix":"10.1007","volume":"30","author":[{"given":"Caroline Paula","family":"Mescka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilian","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Donida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e8e","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto Yasin","family":"Wayhs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziela Schimitt","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Simon","family":"Coitinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moacir","family":"Wajner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Severo","family":"Dutra-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Regla","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,24]]},"reference":[{"key":"9686_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2010.02.018","volume":"1324","author":"AU Amaral","year":"2010","unstructured":"Amaral AU, Leipnitz G, Fernandes CG et al (2010) Alpha-ketoisocaproic acid and leucine provokemitochondrial bioenergetic dysfunction in rat brain. Brain Res 1324:75\u201384","journal-title":"Brain Res"},{"key":"9686_CR2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-0186(00)00100-5","volume":"38","author":"P Ara\u00fajo","year":"2001","unstructured":"Ara\u00fajo P, Wassermann GF, Tallini K et al (2001) Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int 38:529\u2013537","journal-title":"Neurochem Int"},{"key":"9686_CR3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijdevneu.2007.05.004","volume":"25","author":"AG Barschak","year":"2007","unstructured":"Barschak AG, Sitta A, Deon M et al (2007) Erythrocyte glutathione peroxidase activity and plasma selenium concentration are reduced in maple syrup urine disease patients during treatment. Int J Dev Neurosci 25:335\u2013338","journal-title":"Int J Dev Neurosci"},{"key":"9686_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0736-5748(03)00074-1","volume":"21","author":"R Bridi","year":"2003","unstructured":"Bridi R, Araldi J, Sgarbi M et al (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci 21:327\u2013332","journal-title":"Int J Dev Neurosci"},{"key":"9686_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10715760400022350","volume":"39","author":"R Bridi","year":"2005","unstructured":"Bridi R, Latini A, Braum CA et al (2005a) Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral cortex of young rats. Free Radic Res 39:71\u201379","journal-title":"Free Radic Res"},{"key":"9686_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11011-005-4152-8","volume":"20","author":"R Bridi","year":"2005","unstructured":"Bridi R, Braun CA, Zorzi GK et al (2005b) a-Keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defenses in cerebral cortex from young rats. Metab Brain Dis 20:155\u2013167","journal-title":"Metab Brain Dis"},{"key":"9686_CR7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/ars.2012.4785","volume":"19","author":"B Br\u00fcne","year":"2013","unstructured":"Br\u00fcne B, Dehne N, Grossmann N et al (2013) Redox control of inflammation in macrophages. Antioxid Redox Signal 19:595\u2013637","journal-title":"Antioxid Redox Signal"},{"key":"9686_CR8","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/clinchem\/43.11.2106","volume":"43","author":"DH Chace","year":"1997","unstructured":"Chace DH, Hillman SL, Van Hove JL, Naylor EW (1997) Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin Chem 43:2106\u20132113","journal-title":"Clin Chem"},{"key":"9686_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3476(98)70523-2","volume":"132","author":"DT Chuang","year":"1998","unstructured":"Chuang DT (1998) Maple syrup urine disease: it has come a long way. J Pediatr 132:17\u201323","journal-title":"J Pediatr"},{"key":"9686_CR10","first-page":"1971","volume-title":"The metabolic and molecular bases of inherited disease","author":"DT Chuang","year":"2001","unstructured":"Chuang DT, Shih VE (2001) Maple syrup urine disease (branched- chain ketoaciduria). In: Scriver CR, Beaudt AL, Sly WL, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1971\u20132005"},{"key":"9686_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10072-012-0952-x","volume":"34","author":"M Cuturic","year":"2013","unstructured":"Cuturic M, Abramson RK, Moran RR et al (2013) Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington\u2019s disease patients. Neurol Sci 34:93\u201398","journal-title":"Neurol Sci"},{"key":"9686_CR12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbadis.2013.02.001","volume":"1832","author":"R Simone De","year":"2013","unstructured":"De Simone R, Vissicchio F, Mingarelli C et al (2013) Branched-chain amino acids influence the immune properties of microglial cells and their responsiveness to pro-inflammatory signals. Biochim Biophys Acta 1832:650\u2013659","journal-title":"Biochim Biophys Acta"},{"key":"9686_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0167-5699(95)80159-6","volume":"16","author":"G Famularo","year":"1995","unstructured":"Famularo G, De Simone C (1995) A new era for carnitine? Immunol Today 16:211\u2013213","journal-title":"Immunol Today"},{"key":"9686_CR14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1196\/annals.1320.012","volume":"1033","author":"G Famularo","year":"2004","unstructured":"Famularo G, De Simone C, Trinchieri V, Mosca L (2004) Carnitines and its congeners: a metabolic pathway to the regulation of immune response and inflammation. Ann N Y Acad Sci 1033:132\u2013138","journal-title":"Ann N Y Acad Sci"},{"key":"9686_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1014004414733","volume":"17","author":"FU Fontella","year":"2002","unstructured":"Fontella FU, Gassen E, Pulronik V et al (2002) Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47\u201354","journal-title":"Metab Brain Dis"},{"key":"9686_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1320.001","volume":"1033","author":"DW Foster","year":"2004","unstructured":"Foster DW (2004) The role of the carnitine system in human metabolism. Ann NY Acad Sci 1033:1\u201316","journal-title":"Ann NY Acad Sci"},{"key":"9686_CR17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","volume":"112","author":"DM Frazier","year":"2014","unstructured":"Frazier DM, Allgeier C, Homer C et al (2014) Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach. Mol Genet Metab 112:210\u2013217","journal-title":"Mol Genet Metab"},{"key":"9686_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijdevneu.2015.02.003","volume":"42","author":"G Guerreiro","year":"2015","unstructured":"Guerreiro G, Mescka CP, Sitta A et al (2015) Urinary biomarkers of oxidative damage in maple syrup urine disease: the l-carnitine role. Int J Dev Neurosci 42:10\u201314","journal-title":"Int J Dev Neurosci"},{"key":"9686_CR19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.lfs.2005.05.103","volume":"78","author":"I Gulcin","year":"2006","unstructured":"Gulcin I (2006) Antioxidant and antiradical activities of L-carnitine. Life Sci 78:803\u2013811","journal-title":"Life Sci"},{"key":"9686_CR20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.18433\/J3JS4C","volume":"16","author":"S Hatamkhani","year":"2013","unstructured":"Hatamkhani S, Karimzadeh I, Elyasi S et al (2013) Carnitine and sepsis: a review of an old clinical dilemma. J Pharm Pharm Sci 16:414\u2013423","journal-title":"J Pharm Pharm Sci"},{"key":"9686_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1203\/01.pdr.0000190571.60385.34","volume":"59","author":"B Hoffmann","year":"2006","unstructured":"Hoffmann B, Helbling C, Schadewaldt P, Wendel U (2006) Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD. Pediatr Res 59:17\u201320","journal-title":"Pediatr Res"},{"key":"9686_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000071709","volume":"49","author":"VN Izg\u00fct-Uysal","year":"2003","unstructured":"Izg\u00fct-Uysal VN, A\u011fa\u00e7 A, Derin N (2003) Effect of L-carnitine on carrageenan-induced inflammation in aged rats. Gerontology 49:287\u2013292","journal-title":"Gerontology"},{"key":"9686_CR23","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1091\/mbc.11.5.1919","volume":"11","author":"P Jouvet","year":"2000","unstructured":"Jouvet P, Rustin P, Taylor DL et al (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919\u20131932","journal-title":"Mol Biol Cell"},{"key":"9686_CR24","first-page":"362","volume":"22","author":"M Karatepe","year":"2004","unstructured":"Karatepe M (2004) Simultaneous determination of ascorbic acid and free malondialdehyde in human serum by HPLC\u2013UV. LCGC N Am 22:362\u2013365","journal-title":"LCGC N Am"},{"key":"9686_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1515\/hsz-2013-0241","volume":"395","author":"J Lugrin","year":"2014","unstructured":"Lugrin J, Rosenblatt-Velin N, Parapanov R, Liaudet L (2014) The role of oxidative stress during inflammatory process. Biol Chem 395:203\u2013230","journal-title":"Biol Chem"},{"key":"9686_CR26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11011-011-9260-z","volume":"26","author":"M Malaguarnera","year":"2011","unstructured":"Malaguarnera M, Vacante M, Motta M et al (2011a) Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis 26:281\u2013289","journal-title":"Metab Brain Dis"},{"key":"9686_CR27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3109\/00365521.2011.565067","volume":"46","author":"M Malaguarnera","year":"2011","unstructured":"Malaguarnera M, Bella R, Vacante M et al (2011b) Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol 46:750\u2013759","journal-title":"Scand J Gastroenterol"},{"key":"9686_CR28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4330\/wjc.v6.i6.462","volume":"6","author":"H Mangge","year":"2014","unstructured":"Mangge H, Becker K, Fuchs D, Gostner JM (2014) Antioxidants: inflammation and cardiovascular disease. World J Cardiol 6:462\u2013477","journal-title":"World J Cardiol"},{"key":"9686_CR29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijdevneu.2012.10.109","volume":"31","author":"CP Mescka","year":"2013","unstructured":"Mescka CP, Wayhs CA, Vanzin CS (2013) Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect. Int J Dev Neurosci 31:21\u201324","journal-title":"Int J Dev Neurosci"},{"key":"9686_CR30","doi-asserted-by":"crossref","first-page":"610950","DOI":"10.1155\/2013\/610950","volume":"2013","author":"A Mu\u00f1oz","year":"2013","unstructured":"Mu\u00f1oz A, Costa M (2013) Nutritionally mediated oxidative stress and inflammation. Oxidative Med Cell Longev 2013:610950","journal-title":"Oxidative Med Cell Longev"},{"key":"9686_CR31","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1189\/jlb.0313153","volume":"94","author":"S Muralidharan","year":"2013","unstructured":"Muralidharan S, Mandrekar P (2013) Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol 94:1167\u20131184","journal-title":"J Leukoc Biol"},{"key":"9686_CR32","doi-asserted-by":"crossref","first-page":"102158","DOI":"10.1155\/2014\/102158","volume":"2014","author":"M Muriach","year":"2014","unstructured":"Muriach M, Flores-Bellver M, Romero FJ, Barcia JM (2014) Diabetes and the brain: oxidative stress, inflammation, and authophagy. Oxidative Med Cell Longev 2014:102158","journal-title":"Oxidative Med Cell Longev"},{"key":"9686_CR33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.jrn.2004.09.031","volume":"15","author":"G Pertosa","year":"2005","unstructured":"Pertosa G, Grandaliano G, Simone S et al (2005) Inflammation and carnitine in hemodialysis patients. J Ren Nutr 15:8\u201312","journal-title":"J Ren Nutr"},{"key":"9686_CR34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0003-9861(92)90589-O","volume":"296","author":"AZ Reznick","year":"1992","unstructured":"Reznick AZ, Kagan VE, Ramsey R et al (1992) Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusiom injury: the possible role of iron chelation. Arch Biochem Biophys 296:394\u2013401","journal-title":"Arch Biochem Biophys"},{"key":"9686_CR35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.gene.2013.10.017","volume":"533","author":"GS Ribas","year":"2014","unstructured":"Ribas GS, Vargas CR, Wajner M (2014) L-carnitine supplementation as a potencial antioxidant therapy for inherited neurometabolic disorders. Gene 533:469\u2013476","journal-title":"Gene"},{"key":"9686_CR36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11064-007-9423-9","volume":"33","author":"CA Ribeiro","year":"2008","unstructured":"Ribeiro CA, Sgaravatti AM, Rosa RB et al (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumu- lating in maple syrup urine disease. Neurochem Res 33:114\u2013124","journal-title":"Neurochem Res"},{"key":"9686_CR37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12035-013-8618-0","volume":"50","author":"G Scaini","year":"2014","unstructured":"Scaini G, Morais MO, Galant LS et al (2014) Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood\u2013brain barrier breakdown. Mol Neurobiol 50:358\u2013367","journal-title":"Mol Neurobiol"},{"key":"9686_CR38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","volume":"82","author":"S Sch\u00f6nberger","year":"2004","unstructured":"Sch\u00f6nberger S, Schweiger B, Schwahn B et al (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69\u201375","journal-title":"Mol Genet Metab"},{"key":"9686_CR39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2003.09.010","volume":"1639","author":"AM Sgaravatti","year":"2003","unstructured":"Sgaravatti AM, Rosa RB, Schuck PF et al (2003) Inhibition of brain energy metabolism by the \u03b1-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232\u2013238","journal-title":"Biochim Biophys Acta"},{"key":"9686_CR40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1542-4758.2010.00476.x","volume":"14","author":"A Shakeri","year":"2010","unstructured":"Shakeri A, Tabibi H, Hedayati M (2010) Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia. Hemodial Int 14:498\u2013504","journal-title":"Hemodial Int"},{"key":"9686_CR41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10571-013-0002-0","volume":"34","author":"A Sitta","year":"2014","unstructured":"Sitta A, Ribas GS, Mescka CP et al (2014) Neurological damage in MSUD: the role of oxidative stress. Cell Mol Neurobiol 34:157\u2013165","journal-title":"Cell Mol Neurobiol"},{"key":"9686_CR42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","volume":"99","author":"KA Strauss","year":"2010","unstructured":"Strauss KA, Wardley B, Robinson D et al (2010) Classical maple syrup urine disease and brain development: principles of management and formula design. Mol Genet Metab 99:333\u2013345","journal-title":"Mol Genet Metab"},{"key":"9686_CR43","first-page":"324","volume":"28","author":"J Szefel","year":"2012","unstructured":"Szefel J, Kruszzewski WJ, Ciesielski M et al (2012) L-carnitine and cancer cachexia. II. Effects of lipid emulsion used in total parenteral nutrition on parameters of hemostasis and inflammatory state in L-carnitine deficiency in myocytes. Oncol Rep 28:324\u2013329","journal-title":"Oncol Rep"},{"key":"9686_CR44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(00)00402-0","volume":"181","author":"RG Tavares","year":"2000","unstructured":"Tavares RG, Santos CE, Tasca CI et al (2000) Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 181:44\u201349","journal-title":"J Neurol Sci"},{"key":"9686_CR45","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/bjc.1995.482","volume":"72","author":"BK Winter","year":"1995","unstructured":"Winter BK, Fiskum G, Gallo LL (1995) Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer 72:1173\u20131179","journal-title":"Br J Cancer"},{"key":"9686_CR46","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1023\/A:1027325620983","volume":"22","author":"HR Zielke","year":"1997","unstructured":"Zielke HR, Huang Y, Baab PJ et al (1997) Effect of alpha-ketoisocaproate and leucine on the in vivo oxidation of glutamate and glutamine in the rat brain. Neurochem Res 22:1159\u20131164","journal-title":"Neurochem Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-015-9686-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-015-9686-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-015-9686-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T14:35:44Z","timestamp":1599057344000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-015-9686-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,24]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["9686"],"URL":"https:\/\/doi.org\/10.1007\/s11011-015-9686-9","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,24]]}}}